The following is the text of an announcement released to The Stock Exchange of Hong Kong Limited on 18 July 2025 pursuant to rule 13.43 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited:

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document.

18 July 2025

(Hong Kong Stock Code: 5)

HSBC HOLDINGS PLC

INTERIM RESULTS FOR 2025 AND CONSIDERATION OF PAYMENT OF SECOND INTERIM DIVIDEND FOR 2025

Pursuant to Rule 13.43 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited, notice is given that a meeting of a committee of the Board of Directors of HSBC Holdings plc will be held on 30 July 2025 (the "Board Meeting") to consider the announcement of the interim results for the six month period ended 30 June 2025 (the "Results") and to consider the payment of a second interim dividend for 2025 on the ordinary shares (the "Dividend").

Subject to the approval and confirmation at the Board Meeting, the Dividend will be payable on 26 September 2025 to holders of record on 15 August 2025 on the Principal register in the United Kingdom, the Hong Kong Overseas Branch register, the Bermuda Overseas Branch register and for holders of American Depositary Shares in New York.

Further details of the Dividend will be detailed in the Results announcement if approved at the Board Meeting.

For and on behalf of

HSBC Holdings plc

Aileen Taylor

Company Secretary

The Board of Directors of HSBC Holdings plc as at the date of this announcement comprises:

Sir Mark Edward Tucker*, Georges Bahjat Elhedery, Geraldine Joyce Buckingham^†, Rachel Duan^†, Dame Carolyn Julie Fairbairn^†, James Anthony Forese^†, Ann Frances Godbehere^†, Steven Craig Guggenheimer^†, Manveen (Pam) Kaur, Dr José Antonio Meade Kuribreña^†, Kalpana Jaisingh Morparia^†, Eileen K Murray^†, Brendan Robert Nelson^† and Swee Lian Teo^†.

* Non-executive Group Chairman

^†    Independent non-executive Director